Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

about

Dasatinib-Induced Rhabdomyolysis in a 33-Year-Old Patient with Chronic Myeloid Leukemia.

P2860

Q55332510-47E19872-BEB8-4862-849C-86C27A6B2A7E

P2860

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

Item

http://www.wikidata.org/entity/Q54239324

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@en

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@nl

type

Item

label

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@en

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@nl

prefLabel

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@en

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@nl

P1476

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

@en

P2093

Branka Čučević

http://www.w3.org/2001/XMLSchema#string

Davorka Muršić

http://www.w3.org/2001/XMLSchema#string

Marko Jakopović

http://www.w3.org/2001/XMLSchema#string

Marta Koršić

http://www.w3.org/2001/XMLSchema#string

Mihovil Roglić

http://www.w3.org/2001/XMLSchema#string

Nada Božina

http://www.w3.org/2001/XMLSchema#string

Sonja Badovinac

http://www.w3.org/2001/XMLSchema#string

P2860

Pharmacogenetic pathway analysis for determination of sunitinib-induced toxicity.

SLCO1B1 variants and statin-induced myopathy--a genomewide study

Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Adverse drug reactions. A critical review.

Rhabdomyolysis-induced acute kidney injury in a cancer patient exposed to denosumab and abiraterone: a case report

Erlotinib antagonizes ABC transporters in acute myeloid leukemia.

Erlotinib (Tarceva, OSI-774) antagonizes ATP-binding cassette subfamily B member 1 and ATP-binding cassette subfamily G member 2-mediated drug resistance.

Twelve-month frequency of drug-metabolizing enzyme and transporter-based drug-drug interaction potential in patients receiving oral enzyme-targeted kinase inhibitor antineoplastic agents.

The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes.

Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC).

P2888

s00280-015-2885-6

P304

1317-1319

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00280-015-2885-6

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-10-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

283049409

http://www.w3.org/2001/XMLSchema#string

P698

26482820

http://www.w3.org/2001/XMLSchema#string

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

about

P2860

P2860

Erlotinib-related rhabdomyolysis: the role of pharmacogenetics and drug-drug interaction.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P5875

P698